Skip NavigationMarketsBusinessInvestingTechPoliticsVideoWatchlistInvesting Club
PRO
LivestreamMenu
Annika Kim Constantino covers the biotech and pharmaceutical industry for CNBC. She joined CNBC in June 2021 as a digital news intern and served as a news associate before joining the health team.
Annika graduated with a bachelor’s degree from the University of California, Berkeley in 2022.
Latest
Food supply ‘not at risk’ after new Texas screwworm cases, USDA secretary saysAnnika Kim Constantino20 Min AgoAs the largest World Cup ever kicks off, health officials are focused on more than EbolaAnnika Kim ConstantinoJune 4, 2026watch nowVIDEO03:32Ebola isn’t the biggest health risk at the World Cup. Here’s what to watch for insteadNatalie Rice|Annika Kim ConstantinoJune 4, 2026CVS to restore coverage of Zepbound, add Eli Lilly’s obesity pill to drug plansAnnika Kim ConstantinoMay 28, 2026Trump officials hit California with Medicaid funding freeze and threaten other statesAnnika Kim ConstantinoMay 27, 2026Healthy Returns: Eli Lilly makes a new push into vaccines — here’s what to knowAnnika Kim ConstantinoMay 27, 2026watch nowVIDEO02:42Eli Lilly says next-generation weight loss drug clears crucial obesity trialAnnika Kim ConstantinoMay 21, 2026Eli Lilly says next-generation weight loss drug clears crucial obesity trialAnnika Kim ConstantinoMay 21, 2026White House adds generic drugs to direct-to-consumer TrumpRx siteAnnika Kim ConstantinoMay 18, 2026CDC says American tests positive for Ebola in Africa, risk in the U.S. remains lowAnnika Kim ConstantinoMay 18, 2026CDC says there are no U.S. hantavirus cases currently, 41 people being monitoredAnnika Kim Constantino|Jacob PramukMay 14, 2026Hantavirus outbreak isn’t another Covid pandemic – but experts say it’s testing U.S. readinessAnnika Kim ConstantinoMay 14, 2026
About The Author
